About Accuri Cytometers
Accuri Cytometers is a Healthcare company based in Ann Arbor (United States) founded in 2004, and was acquired by Becton Dickinson in February 2011. Compact flow cytometers for cell analysis are developed and provided. Accuri Cytometers has raised $30.91 million across 7 funding rounds from investors including Credit Suisse, BD and Flagship Pioneering. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Cell Biology. Its competitors include Cytek Biosciences, ACEA Biosciences and Bioaffinity technologies; 3 of its 3 listed competitors have raised funding.
Company details
Accuri Cytometers developed Accuri C6 which is used in flow cytometry. Its is a compact and portable device to be used by novice and experienced researchers. The system features an software interface, software templates, and reagent kits that guide users new to flow cytometry through workflows for popular applications. Used in Immunophenotyping, Cell finction analysis, gene expression, non-mammalian studies and DNACell cycle analysis.
- Headquarters Ann Arbor, United States
- Stage Acquired
- SectorsHealthcare
- Website accuricytometers.com
- Social LinkedIn
- Acquired by Becton Dickinson (Feb 2011)
- Total Equity Funding$30.91M (USD)
in 7 rounds
- Latest Funding Round$6M (USD), Series E
Jul 2010
- InvestorsCredit Suisse
& 6 more
- Acquired byBecton Dickinson
(Feb 2011)
Funding Insights of Accuri Cytometers
Accuri Cytometers has successfully raised a total of $30.91M across 7 strategic funding rounds. The most recent funding activity was a Series E round of $6 million completed in July 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $30.91M
- Total Rounds 7
- Last Round Series E — $6M
- First Round $805,000
(Mar 2005)
- Investors Count 6
All 7 funding rounds of Accuri Cytometers with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2010 | $6M | Series E | – | Arboretum Ventures, InvestMichigan! | – |
| Jul 2009 | $4M | Series D | – | InvestMichigan!, Arboretum Ventures | |
| Jul 2008 | $13M | Series C | – | F-Prime Capital, Flagship Pioneering | |
| Jun 2008 | $2M | Series B | – | – | – |
| Sep 2007 | $100,000 | Series B | – | – | – |
| Apr 2007 | $5M | Series B | – | – | |
| Mar 2005 | $805,000 | Seed | – | – | – |
7 investors in total: 7 institutional.
Investors in Accuri Cytometers
Accuri Cytometers has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Credit Suisse, BD and Flagship Pioneering.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare venture capital investments are made by Arboretum Ventures. | arboretumvc.com | Ann Arbor, United States | ||
Private equity investments are directed toward US companies. | investmichiganfund.com | Michigan, United States | ||
Life sciences-focused venture capital firm | 1999 | flagshippioneering.com | Cambridge, United States | |
Global private equity and venture capital investments in B2B Tech & Services companies. | bairdcapital.com | |||
Investments in life sciences, technology, healthtech, and crypto sectors from global locations. | fprimecapital.com | |||
Wealth management, asset management, and investment banking services are offered. | 1856 | credit-suisse.com | Zurich, Switzerland | |
BD is recognized for providing innovative medical technology solutions. | 1897 | bd.com | Franklin Lakes, United States |
Investor details for Accuri Cytometers
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Accuri Cytometers
4 dated milestones of Accuri Cytometers across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Accuri Cytometers is founded.
- Funding First funding round of $805K.
- Funding Latest funding round, Series E, of $6.0M.
- Exit Acquired by Becton Dickinson.
Competitors of Accuri Cytometers
Accuri Cytometers has 3 listed competitors in our database, 3 of them funded. They include Cytek Biosciences, ACEA Biosciences and Bioaffinity technologies.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cytekbio.com | 2014 | San Francisco, United States | $132M | 676 | Advanced flow cytometry systems are manufactured for research applications. | |
| aceabio.com | 2002 | San Diego, United States | $37.89M | 5,968 | Instruments for life science research are developed and marketed. | |
| bioaffinitytech.com | 2014 | San Antonio, United States | $9.05M | 65 | IVD platforms are developed to detect and target cancer cells. |
Detailed competitors of Accuri Cytometers
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Accuri Cytometers
Websites that share an audience with Accuri Cytometers (accuricytometers.com).
Websites whose visitors overlap most with Accuri Cytometers. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bdbiosciences.com | 100% | 331.8K | #154,504 | View details | |
ucflow.uchicago.edu | ucflow.uchicago.edu | 94% | – |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Accuri Cytometers (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Accuri Cytometers
Complete news archive for Accuri Cytometers
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Accuri Cytometers
Accuri Cytometers was founded in 2004 and raised its 1st funding round 1 year after it was founded.
Accuri Cytometers is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.
Accuri Cytometers is a funded company, having raised a total of $30.91M across 7 funding rounds to date. The company's 1st funding round was a Seed of $805K, raised on Mar 2005.
Accuri Cytometers developed Accuri C6 which is used in flow cytometry. Its is a compact and portable device to be used by novice and experienced researchers. The system features an software interface, software templates, and reagent kits that guide users new to flow cytometry through workflows for popular applications. Used in Immunophenotyping, Cell finction analysis, gene expression, non-mammalian studies and DNACell cycle analysis.
Accuri Cytometers's top competitors include Cytek Biosciences, Bioaffinity technologies and ACEA Biosciences.
Accuri Cytometers has 7 investors. Key investors include Credit Suisse, BD, Flagship Pioneering, Arboretum Ventures, and InvestMichigan!.
Yes. Accuri Cytometers was acquired by Becton Dickinson in February 2011.